Cargando…
Infantile/Congenital High-Grade Gliomas: Molecular Features and Therapeutic Perspectives
Brain tumors in infants account for less than 10% of all pediatric nervous system tumors. They include tumors diagnosed in fetal age, neonatal age and in the first years of life. Among these, high-grade gliomas (HGGs) are a specific entity with a paradoxical clinical course that sets them apart from...
Autores principales: | Ceglie, Giulia, Vinci, Maria, Carai, Andrea, Rossi, Sabrina, Colafati, Giovanna Stefania, Cacchione, Antonella, Tornesello, Assunta, Miele, Evelina, Locatelli, Franco, Mastronuzzi, Angela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555400/ https://www.ncbi.nlm.nih.gov/pubmed/32872331 http://dx.doi.org/10.3390/diagnostics10090648 |
Ejemplares similares
-
LGG-18. EVEROLIMUS TREATMENT IN PEDIATRIC PATIENTS AFFECTED BY LOW-GRADE GLIOMAS (pLGG) NON-TSC, BRAF v600-WT
por: Cacchione, Antonella, et al.
Publicado: (2020) -
Molecular Landscape in Infant High-Grade Gliomas: A Single Center Experience
por: Di Ruscio, Valentina, et al.
Publicado: (2022) -
Cancer Predisposition Syndromes Associated With Pediatric High-Grade Gliomas
por: Ceglie, Giulia, et al.
Publicado: (2020) -
HGG-54. HISTOLOGICAL AND MOLECULAR CHARACTERIZATION OF HIGH-GRADE BRAIN TUMORS SECONDARY TO TOTAL BODY IRRADIATION FOR HEMATOLOGICAL MALIGNANCIES
por: Miele, Evelina, et al.
Publicado: (2020) -
BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas
por: Del Bufalo, Francesca, et al.
Publicado: (2018)